299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

8 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03965832 (ClinicalTrials.gov)	May 24, 2019	24/5/2019	HFNT During Exercise in CF	A Pilot Study to Evaluate the Feasibility of Using High-flow Nasal Therapy During Exercise in Patients With Cystic Fibrosis and Severe Lung Disease	Cystic Fibrosis	Device: HFNT during exercise;Device: Standard oxygen therapy/RA	The Leeds Teaching Hospitals NHS Trust	NULL	Recruiting	18 Years	N/A	All	20	N/A	United Kingdom
2	NCT03902236 (ClinicalTrials.gov)	March 1, 2019	1/4/2019	Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis	Evaluation of Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis	Cystic Fibrosis;Bronchiectasis	Other: Reaction Time and Postural Control;Other: Muscle oxygenation;Other: Exercise capacity;Other: Balance	Hacettepe University	NULL	Recruiting	6 Years	18 Years	All	60		Turkey
3	NCT02684552 (ClinicalTrials.gov)	February 2016	12/2/2016	Non Invasive Ventilation During Physical Training in Cystic Fibrosis	Physiotherapist in Charge of the Study	Cystic Fibrosis	Device: Non invasive ventilation;Device: Oxygen	Karolinska University Hospital	NULL	Completed	18 Years	90 Years	Both	8	N/A	Sweden
4	NCT02262871 (ClinicalTrials.gov)	December 2014	7/10/2014	HFN Versus NIV in Cystic Fibrosis. The HIFEN Study	Randomized Cross-over Physiologic Study of High Flow Nasal Oxygen Cannula Versus Non-invasive Ventilation in Cystic Fibrosis. The HIFEN Study	Cystic Fibrosis	Device: High flow nasal oxygen cannula;Device: Noninvasive ventilation	St. Michael's Hospital, Toronto	NULL	Completed	18 Years	N/A	All	15	N/A	Canada
5	NCT01586728 (ClinicalTrials.gov)	October 2012	18/1/2012	Oxygen Therapy in Cystic Fibrosis	Indication and Benefits of Nocturnal Oxygen Therapy in Cystic Fibrosis	Cystic Fibrosis	Other: Air - oxygen;Other: Oxygen - Air	Assistance Publique - Hôpitaux de Paris	Vaincre la Mucoviscidose	Terminated	6 Years	N/A	Both	8	N/A	France
6	NCT01731015 (ClinicalTrials.gov)	January 2012	16/11/2012	Imaging Lung Function Using Oxygen Enhanced MRI	A Pilot Study for Evaluation of Regional Lung Function in Normal Subjects and Subjects With Airway and Lung Disorders Using 1H Magnetic Resonance Imaging With Oxygen as a Contrast Agent	COPD;Asthma;Cystic Fibrosis;Emphysema;Small Airways Disease	Drug: Medical Grade Oxygen	Hal C Charles	NULL	Completed	18 Years	90 Years	Both	15	Phase 1	United States
7	NCT01710449 (ClinicalTrials.gov)	September 2009	17/10/2012	Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen	Evaluation of Regional Ventilation in Normal Subjects and Subjects With Airway and Lung Disorders (COPD, Asthma, Emphysema, Small Airway Disease and Cystic Fibrosis) Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen.	COPD;Asthma;Cystic Fibrosis;Emphysema;Small Airways Diseases	Drug: perfluorinated gas/oxygen mixture	Hal C Charles	NULL	Completed	18 Years	N/A	Both	44	Phase 1	United States
8	NCT00157183 (ClinicalTrials.gov)	March 2003	9/9/2005	Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation	Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation	Cystic Fibrosis	Device: Nocturnal oxygen , nocturnal bi-level positive pressure ventilation	Bayside Health	National Health and Medical Research Council, Australia;Monash University;Cystic Fibrosis Australia	Completed	18 Years	75 Years	Both	59	Phase 1/Phase 2	Australia

先頭へ